ADHD stimulant medication misuse and considerations for current prescribing practice: a literature review
- 9 February 2021
- journal article
- review article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 191 (1) , 313-320
Abstract
Background Stimulant medications have been prescribed to effectively treat childhood Attention Deficit Hyperactivity Disorder (ADHD) since the 1960’s, with improved outcomes observed in the three core symptom domains. Over the course of these decades researchers and clinicians have debated the issue of negative outcomes with regard to later development of substance use disorders (SUD) for these children. Aims To chronicle the development of medical and scientific opinion on the subject of SUD outcomes in ADHD and to appraise most recently published research in this sphere. Methods A systematic search of the literature was conducted over 4 databases. Removal of duplicates, application of exclusion criteria and inclusion of publications identified through manual and citation-based search yielded 9 papers. Results Prescriptions for stimulant medications are increasing worldwide and in tandem the prevalence of stimulant misuse. Much research focuses on non-medical stimulant misuse as a study aid; however, they are also used as recreational drugs with action on dopaminergic neurotransmitter pathways implicated in addiction disorders. Considering the risks and benefits of stimulant prescribing on later SUD development research in recent decades has produced inconsistent results. Current research supports the hypothesis of improved SUD outcomes for young people treated early and intensely, with poorer outcomes for those with less robust treatment histories. Conclusions Consideration of the impact that variable treatment trajectories may have on the risk of later SUD development is recommended, with further research potentially leading to the development of different management pathways based on an individual’s multivariate treatment profile.Keywords
This publication has 51 references indexed in Scilit:
- Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studiesBMC Psychiatry, 2013
- “Adderall is Definitely Not a Drug”: Justifications for the Illegal Use of ADHD StimulantsSubstance Use & Misuse, 2009
- Nonmedical Prescription Stimulant Use Among a Sample of College StudentsJournal of Attention Disorders, 2009
- Characteristics and Motives of College Students Who Engage in Nonmedical Use of MethylphenidateThe American Journal on Addictions, 2008
- Age of Methylphenidate Treatment Initiation in Children With ADHD and Later Substance Abuse: Prospective Follow-Up Into AdulthoodAmerican Journal of Psychiatry, 2008
- Attention deficit/hyperactivity disorder: complexities and controversiesCurrent Opinion in Pediatrics, 2006
- The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relativesPsychiatric Clinics of North America, 2004
- Influence of Gender on Attention Deficit Hyperactivity Disorder in Children Referred to a Psychiatric ClinicAmerican Journal of Psychiatry, 2002
- Addictive Drugs and Brain Stimulation RewardAnnual Review of Neuroscience, 1996
- Juvenile Delinquency and Attention Deficit Disorder: Boys' Developmental Trajectories from Age 3 to Age 15Child Development, 1990